Готові списки джерел за темами / Treatment and prevention of tuberculosis

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Treatment and prevention of tuberculosis"

Автор: Grafiati
Опубліковано: 3 червня 2025
Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Treatment and prevention of tuberculosis".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Treatment and prevention of tuberculosis"

1

Lindesmith, Larry A. "Tuberculosis: Prevention and Treatment." Journal of Occupational & Environmental Medicine 38, no. 4 (1996): 422–23. http://dx.doi.org/10.1097/00043764-199604000-00053.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Shin, Key Chul. "Primary Treatment and Prevention of Tuberculosis." Tuberculosis and Respiratory Diseases 45, no. 6 (1998): 1115. http://dx.doi.org/10.4046/trd.1998.45.6.1115.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gbayisomore, Akingboju, Alfred A. Lardizabal, and Lee B. Reichman. "Update: prevention and treatment of tuberculosis." Current Opinion in Infectious Diseases 13, no. 2 (2000): 155–59. http://dx.doi.org/10.1097/00001432-200004000-00010.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Miggiano, Riccardo, Menico Rizzi, and Davide M. Ferraris. "Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment." Pathogens 9, no. 5 (2020): 385. http://dx.doi.org/10.3390/pathogens9050385.

Повний текст джерела
Анотація:
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Samina, Iqbal Kanji. "Tuberculosis: Moving from cure to prevention in Pakistan." International Journal of Endorsing Health Science Research 3, no. 3 (2015): 27–30. https://doi.org/10.29052/IJEHSR.v3.i3.2015.27-30.

Повний текст джерела
Анотація:
Abstract For many years, most of the world’s population is fighting its battle against the disastrous organism, biologically known as “Mycobacterium Tuberculosis”. According to Gul, Fatima, and Shabbir (2013), tuberculosis (TB) is amongst the leading causes of mortality globally, and 98% of these deaths are unfortunately prevalent in developing countries. Similarly, Pakistan is sharing the huge burden of morbidity and mortality by TB despite the preventable nature of disease. According to World Health Organization (2013), Pakistan is ranking fifth amongst the 22 high TB burde
Стилі APA, Harvard, Vancouver, ISO та ін.
6

OG, Aghedo. "Trends of Tuberculosis Prevalence, Treatment and Prevention Efforts in Yenagoa, Bayelsa State." Public Health Open Access 7, no. 2 (2023): 1–8. http://dx.doi.org/10.23880/phoa-16000248.

Повний текст джерела
Анотація:
Background: Tuberculosis is still rampant in Nigeria, and contributes significantly to TB burden globally. This study was conducted with the main objective of determining the trends of TB prevalence, treatment and preventive efforts by the government of Bayelsa State, and providing insight into the level of progress in the fight against TB in the State. Methods: It is a retrospective study of TB programme data consisting of 10,512 patients who accessed healthcare services at the health facilities from 2017 to 2021. Enrolment registers, TB Treatment registers, Test Result Request Forms and Labo
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zellweger, Jean-Pierre. "Tuberculosis Multidrug-resistant Tuberculosis – From Epidemiology to Treatment Design." European Respiratory & Pulmonary Diseases 01, no. 01 (2015): 20. http://dx.doi.org/10.17925/erpd.2015.01.01.20.

Повний текст джерела
Анотація:
Multidrug-resistant tuberculosis (MDR-TB) and extensively resistant tuberculosis (XDR-TB) are present in most regions of the world and represent a serious threat to the control of tuberculosis. They usually result from errors somewhere along the chain of management of the disease that favoured the selection of resistant mutants, progressively replacing drug-sensitive strains and transmitted to further patients. The currently recommended strategies for the control of this serious situation is the rapid identification of drug-resistant strains, careful drug management of patients with second-lin
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Bastian, Ivan, and Robert Colebunders. "Treatment and Prevention of Multidrug-Resistant Tuberculosis." Drugs 58, no. 4 (1999): 633–61. http://dx.doi.org/10.2165/00003495-199958040-00005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Yamagishi, Fumio. "Epidemiology, Diagnosis, Treatment and Prevention of Tuberculosis." Nihon Naika Gakkai Zasshi 101, no. 6 (2012): 1691–97. http://dx.doi.org/10.2169/naika.101.1691.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Kirsch, Sarah, and Martina Sester. "Tuberculosis in Transplantation: Diagnosis, Prevention, and Treatment." Current Infectious Disease Reports 14, no. 6 (2012): 650–57. http://dx.doi.org/10.1007/s11908-012-0293-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Treatment and prevention of tuberculosis"

1

Djoba, Siawaya Joel Fleury. "Immune parameters as biomarkers of Mycobacterium tuberculosis sterilization during anti-tuberculosis treatment." Thesis, Stellenbosch : Stellenbosch University, 2008. http://hdl.handle.net/10019.1/21436.

Повний текст джерела
Анотація:
Thesis (PhD)--Stellenbosch University, 2008.<br>ENGLISH ABSTRACT: Setting Study conducted in Tygerberg, Cape Town in South Africa. Hypothesis Host biomarkers associated with the antimycobacterial immune response during active infection with M. tuberculosis and during anti-tuberculosis chemotherapy are indicative of bacterial killing in the host and can be used in models to predict eventual treatment outcome. Objectives 1. To investigate immune parameters that were selected in a biological context as biomarkers of the extent of disease and early response to anti-tuberculosis treatment. 2.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Leeming-Latham, Clare Louise. "The seed and the soil : tuberculosis prevention and treatment in England, 1940-1974." Thesis, Birkbeck (University of London), 2012. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.694636.

Повний текст джерела
Анотація:
This thesis investigates the evolution of medical responses to tuberculosis in England between 1940 and 1974. Set against the backdrop of the reorganisation of health care in 1948, it uses case material from the West Midlands to expose how changing national, regional and local circumstances influenced disease prevention and treatment strategies in an under-researched timeframe. Chapter 1 explores the use of BCG vaccination as a tuberculosis prevention measure, within the context of the national and international debates over its efficacy. After analysing the impact of the mass vaccination prog
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Visser, Hanri. "Mechanisms of resistance to new generation anti-TB drugs." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96863.

Повний текст джерела
Анотація:
Thesis (MScMedSc)--Stellenbosch University, 2015.<br>ENGLISH ABSTRACT: Drug resistance in Mycobacterium tuberculosis is an increasing global problem. Drug resistance is mostly caused by single nucleotide polymorphisms (SNPs) within the bacterial genome. This observed increase in global incidence of drug resistant tuberculosis (TB) has sparked the search for new anti-TB drugs and the repurposing of drugs that are currently used against other organisms or species of mycobacteria. One such repurposed drug, clofazimine (CFZ), is currently used for the treatment of leprosy, caused by Mycobacterium
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Richner, Sharon M. "The measurement of genetic diversity in mycobacterium tuberculosis using random amplified polymorphic DNA profiling." Thesis, Rhodes University, 2000. http://hdl.handle.net/10962/d1004068.

Повний текст джерела
Анотація:
Mycobacterium tuberculosis has caused a resurgence in pulmonary disease in both developed and developing countries in recent times, particularly amongst people infected with the human immunodeficiency virus. The disease has assumed epidemic proportions in South Africa and in the Eastern Cape Province in particular. Of further concern is the isolation of increasing numbers of multiply drug resistant strains. Knowledge of the genetic capability of this organism is essential for the successful development of novel antibiotics and vaccines in an attempt to bring the global pandemic under control.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Naidoo, Pamela. "Exploring tuberculosis (TB) patient's adherence to treatment regimens and prevention programmes at a public healt site." Master's thesis, University of Cape Town, 2006. http://hdl.handle.net/11427/9431.

Повний текст джерела
Анотація:
Includes bibliographical references.<br>The aim of this study was to explore the factors that contribute to TB patient's adherence to the Directly Observed Treatment Short-Course (DOTS) strategy and the factors that serve as barriers to adherence. The study was set in a historically disadvantaged township, KhayeIitsha, a sub-district of the City of Cape Town in the Western Cape Province. A qualitative, phenomenological research design, which is part of an ethnographic tradition, was used.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Musarapasi, Normusa. "Review of outcomes for isoniazid preventive therapy among HIV infected clients at a clinic in Swaziland." University of the Western Cape, 2019. http://hdl.handle.net/11394/6887.

Повний текст джерела
Анотація:
Magister Public Health - MPH<br>Background: TB is one of the most common opportunistic infections in the HIV infected population. In 2014, of the 9.6 million people estimated to have TB globally, 1.2 million were also infected with HIV. In the same year WHO reported 400 000 TB deaths in HIV infected people worldwide. TB Prevention strategies include ensuring HIV infected people take ART, TB infection control, treatment of TB cases and pharmacological prevention of primary TB infection or progression of latent TB into active TB. Isoniazid preventive therapy for a minimum of six months has been
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Dobler, Claudia Caroline. "Towards a decision aid for treatment of latent tuberculosis infection." Thesis, The University of Sydney, 2013. http://hdl.handle.net/2123/11732.

Повний текст джерела
Анотація:
The decision to give preventive treatment to a person with latent tuberculosis infection (LTBI) is a complex one in which morbidity and mortality from potential progression to active tuberculosis (TB) is weighed against the morbidity and mortality associated with potential adverse effects of treatment. Without objective evidence and careful, model-based evaluation of the evidence, it is likely the risks and benefits of the two alternative strategies (treatment or no treatment) will be inaccurately assessed. It is therefore apparent that medical practitioners need assistance when making decisio
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Grobbelaar, Melanie. "Adaptation of the Mycobacterium tuberculosis transcriptome in response to rifampicin." Thesis, Stellenbosch : Stellenbosch University, 2012. http://hdl.handle.net/10019.1/20387.

Повний текст джерела
Анотація:
Thesis (MScMedSc)--Stellenbosch University, 2012.<br>ENGLISH ABSTRACT: Anti-tuberculosis drugs target specific essential cellular processes and structural components. The first line drug, rifampicin (RIF) is a RNA polymerase inhibitor which targets the β-subunit and subsequently inhibits the initiation of transcription. Previous proteomic and transcriptomic analyses have shown that exposure to RIF for 24hrs significantly increased the abundance of proteins involved in energy metabolism in clinical isolates. No studies have been done to describe the transcriptional responses to RIF in an in vit
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Birungi, Francine Mwayuma. "An evaluation of Isoniazid prophylaxis treatment and the role of Xpert MTB/RIF test in improving the diagnosis and prevention of tuberculosis in children exposed to index cases with pulmonary tuberculosis in Kigali, Rwanda." University of the Western Cape, 2018. http://hdl.handle.net/11394/6880.

Повний текст джерела
Анотація:
Philosophiae Doctor - PhD<br>Background: Tuberculosis (TB) is a major cause of morbidity and mortality among children (<15 years) in resource-limited countries. The World Health Organization (WHO) identified active contact screening and isoniazid preventive therapy (IPT) as essential actions for detecting and preventing childhood TB. Despite their benefits and inclusion in the policy of most National TB Programme (NTP) guidelines of the resource-limited countries, there is still a wide gap between policy and implementation. The implementation of contact screening for active case finding might
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Rakotonirina, El-C.-Julio. "Contextualiser le programme pour un meilleur contrôle de la tuberculose à Madagascar." Doctoral thesis, Universite Libre de Bruxelles, 2010. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210103.

Повний текст джерела
Анотація:
Résumé exécutif.<p>Introduction.<p>La tuberculose est une maladie infectieuse qui constitue un fardeau pour la société et en ce sens qu’elle est responsable d’un important taux de mortalité spécifique, surtout dans les pays en développement. Malgré les grands progrès en termes de méthodes de diagnostic, de prévention et de traitement, près de 9 millions de nouveaux cas apparaissent chaque année au niveau mondial et les 30% se trouvent en Afrique. On estime que la tuberculose est responsable de près de 2 millions de morts par an, principalement parmi les populations les plus pauvres. Pourtant,
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Treatment and prevention of tuberculosis"

1

National Institute of Allergy and Infectious Diseases (U.S.), ed. Learn about tuberculosis. NIAID, U.S. Dept. of Health and Human Services, National Institutes of Health, 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Hickey, Anthony J., Amit Misra, and P. Bernard Fourie, eds. Drug Delivery Systems for Tuberculosis Prevention and Treatment. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118943182.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Horne, N. W. Modern drug treatment in tuberculosis: (including prevention and control). 7th ed. Chest, Heart and Stroke Association, 1990.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Division, India Central TB, and Revised National Tuberculosis Control Programme for India., eds. Technical guidelines for tuberculosis control. Central TB Division, Directorate General of Health Services, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Kaul, Sunil. An observational study of RNTCP & DOTS strategy in three districts, January'98-March'98. Voluntary Health Association of India, 1998.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

South Africa. Department of National Health and Population Development. The South African tuberculosis control programme: Practical guidelines. Dept. of National Health and Population Development, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zumla, Alimuddin. Tuberculosis: A comprehensive clinical reference. Saunders/Elsevier, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Côté, Louise. En garde!: Les représentations de la tuberculose au Québec dans la première moitié du XXe siècle. Presses de l'Université Laval, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee. Tuberculosis in New York City: An epidemic returns : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, December 18, 1991. U.S. G.P.O., 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Chen, Wenjia. Fujian Sheng fang lao zhi. Fujian Sheng fang lao xie hui, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Treatment and prevention of tuberculosis"

1

Clark, Nina M. "Tuberculosis: Treatment and Prevention." In The AST Handbook of Transplant Infections. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444397949.ch27.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

McMurray, David N. "Animal Models of Tuberculosis." In Drug Delivery Systems for Tuberculosis Prevention and Treatment. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118943182.ch3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gebreselassie, Nebiat, Dennis Falzon, Alberto Matteelli, and Matteo Zignol. "Tuberculosis Preventive Treatment: Key Research Areas and the Clinical Pipeline for New Treatments." In Essential Tuberculosis. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-66703-0_45.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Arnett, Eusondia, Nitya Krishnan, Brian D. Robertson, and Larry S. Schlesinger. "Host Pathogen Biology for AirborneMycobacterium tuberculosis." In Drug Delivery Systems for Tuberculosis Prevention and Treatment. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118943182.ch2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Wong, Jennifer, Maurizio Ricci, and Hak-Kim Chan. "Spray Drying Strategies to Stop Tuberculosis." In Drug Delivery Systems for Tuberculosis Prevention and Treatment. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118943182.ch9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Liu, Shou-jiang, and Wei Wei. "Prevention, Diagnosis, and Treatment of TB in the Migrating Population." In Tuberculosis Control in Migrating Population. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-32-9763-0_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Stanford, John Lawson. "The Immunological Cause, Prevention, and Treatment of Tuberculosis." In Mycobacteria. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Price, Dominique N., and Pavan Muttil. "Directed Intervention and Immunomodulation against Pulmonary Tuberculosis." In Drug Delivery Systems for Tuberculosis Prevention and Treatment. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118943182.ch18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Young, Ellen F., Anthony J. Hickey, and Miriam Braunstein. "Testing Inhaled Drug Therapies for Treating Tuberculosis." In Drug Delivery Systems for Tuberculosis Prevention and Treatment. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118943182.ch6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Marrast, A. C., S. Daoud, J. L. Garnier, et al. "Disseminated Tuberculosis with Pulmonary Miliary and Pharyngeal Localisation in 2 Kidney Transplanted Patients." In Cancer in Transplantation: Prevention and Treatment. Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0175-9_63.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Treatment and prevention of tuberculosis"

1

Rehman, Atif, Syed Hassan Ahmed Shah, Iftikhar Ahmad, and Absaar ul Jabbar. "Enhanced Tuberculosis Treatment and Prevention Using Genetic Algorithm Based Control Techniques." In 2023 20th International Bhurban Conference on Applied Sciences and Technology (IBCAST). IEEE, 2023. http://dx.doi.org/10.1109/ibcast59916.2023.10712972.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Pramanik, Atreyi, Ajay Singh, Gouri Rani, Shival Dubey, and Srinivas Aluvala. "Revolutionizing Tuberculosis Treatment: Smart Technology Innovations for Mycobacterium tuberculosis Management." In 2024 International Conference on Smart Devices (ICSD). IEEE, 2024. http://dx.doi.org/10.1109/icsd60021.2024.10751489.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Kokhreidze, Eka, Zaza Avaliani, Nino Gabashvili, and Maia Zamutashvili. "Observation on Tuberculosis Preventive Treatment in Georgia." In Socratic Lectures 8. University of Lubljana Press, 2023. http://dx.doi.org/10.55295/psl.2023.ii25.

Повний текст джерела
Анотація:
The uptake of latent tuberculosis infection treatment (LTBI) is an important measure to prevent active tuberculosis (TB), but has not been well studied in low and middle-income countries (LMICs). The lifetime risk of developing active TB for people with LTBI is 10-15%. Within the national guidelines of National Tuberculosis control Program (NTP) 2020 in Georgia, 6 months isoniazid preventive treatment (IPT) was replaced with 3 months rifapentine treatment. Here we present the results of the care cascade of LTBI treatment of subjects to whom the Tuberculosis Preventive Treatment (TPT) in Georgi
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Rahmi, Upik. "Knowledge of Supervision on Treatment About Prevention and Infection of Tuberculosis." In 4th International Conference on Sport Science, Health, and Physical Education (ICSSHPE 2019). Atlantis Press, 2020. http://dx.doi.org/10.2991/ahsr.k.200214.035.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Duyar Agca, Filiz, and Onur Aksu Ceyhan. "Preventive treatment for latent tuberculosis infection." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2744.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Zuhri, Zainullah, Abdulloh Hamid, Subchan, and Imam Rofiki. "Optimal Control of Exogenous Reinfection Prevention and Treatment on a Tuberculosis Model." In Built Environment, Science and Technology International Conference 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008904702350239.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Lu, Yueran, Bodong Liu, Yaqing Song, and Yun Yang. "Analysis of Adolescent Tuberculosis Prevention and Treatment by Combining Data Membership and Fuzzy Clustering Algorithm." In 2023 International Conference on Integrated Intelligence and Communication Systems (ICIICS). IEEE, 2023. http://dx.doi.org/10.1109/iciics59993.2023.10420895.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Kurnianingsih, Widya, Didik Gunawan Tamtomo, and Bhisma Murti. "Incomplete Medication Intake and Multidrug Resistant Tuberculosis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.01.58.

Повний текст джерела
Анотація:
Background: Multidrug Resistant Tuberculosis (MDR-TB) is a highest problem in the prevention and eradication of TB worldwide. MDR-TB exists in 27 countries where there are at least 6,800 MDR-TB cases annually and 12% of new TB cases registered are MDR TB. This study aimed to examine the effect of incomplete medication intake on the incidence of MDR TB. Subjects and Method: Meta-analysis and systematic review was conducted by collecting articles from Google Scholar, Pubmed, and Springer Link databases, from year 2010 to 2019. Keywords used “Risk Factor MDR TB” OR “Previous Treatment” AND “Multi
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Freijanes, Loise Maria de Souza, Elisa Yuki Kurosawa Ueda, Paola Restum Antonio Lemaitre, and Isabela Pierotti Prado. "Tuberculous Meningitis: Literature Review." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.163.

Повний текст джерела
Анотація:
Background: Tuberculous meningitis is the most severe form of M.tuberculosis infection, and occurs when there is an invasion of the membranes and cerebrospinal fluid by the bacteria. It develops as a complication of primary infection and reactivation in immunosuppressed. Objectives: This study aims to characterize tuberculous meningitis and bring updates. Design and setting: This is a literature review from the Escola de Medicina Souza Marques‘s students, Brazil. Methods: The used articles were published between 2012 and 2021, from the UpToDate, Scielo, PubMed, and Google Scholar databases. Re
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Alfirdaus, Laila Kholid. "Empowering Tuberculosis-Responsive Village Governments: an Action Research Approach." In 3rd International Conference on Community Engagement and Education for Sustainable Development. AIJR Publisher, 2023. http://dx.doi.org/10.21467/proceedings.151.25.

Повний текст джерела
Анотація:
Through Presidential Regulation No. 67/2021 on Tuberculosis Control, the Government of Indonesia has announced the urgency of an integrative approach to handling TBC diseases, including at the village level. Nonetheless, there are still bottlenecks in the implementation as not all stakeholders know their tasks and responsibility. To this day, TBC has been a domain of the Ministry of Health. It is decentralized up to provincial, regency, and sub-district levels through Community Health Services (Pusat Kesehatan Masyarakat or Puskesmas). In fact, inadequacy can still be found in policy strategie
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Treatment and prevention of tuberculosis"

1

Ciapponi, Agustín. Do workplace programmes for the diagnosis and treatment of HIV improve workers’ health outcomes and attitudes? SUPPORT, 2017. http://dx.doi.org/10.30846/1705132.

Повний текст джерела
Анотація:
The HIV epidemic may threaten the health workforce by imposing heavier workloads and increasing complexity of care; by exposing health workers and other workers living with HIV and AIDS to tuberculosis (TB) and other infectious diseases; and through the psychological stress placed on health workers who have to administer care. HIV and AIDS may also have substantial impacts on the workforce in sectors other than health. Workplace programmes aim to improve access for health workers and other workers to HIV prevention, treatment and support.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Haider, Huma. Malaria, HIV and TB in Nigeria: Epidemiology and Disease Control Challenges. Institute of Development Studies (IDS), 2021. http://dx.doi.org/10.19088/k4d.2022.040.

Повний текст джерела
Анотація:
Nigeria has the world’s highest number of people affected by malaria and the world’s second largest human immunodeficiency virus (HIV)/AIDS burden. There is a high occurrence of co-infection of malaria in HIV patients (Gumel et al., 2021). Nigeria is also ranked as one of the thirty high tuberculosis (TB) and TB-HIV co-infection burden countries in the world (Odume et al., 2020, 8). Co-infection can make each disease more severe and potentially more infectious (Gumel et al., 2021; Jemikalajah et al., 2021; Chukwuocha et al., 2019). This rapid literature review highlights key aspects of the epi
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Повний текст джерела
Анотація:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et a
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Повний текст джерела
Анотація:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et a
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Повний текст джерела
Анотація:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et a
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Bain, Luchuo Engelbert, and Darja Dobermann. Malaria, HIV and TB in the Democratic Republic of the Congo: Epidemiology, Disease Control Challenges and Interventions. Institute of Development Studies (IDS), 2022. http://dx.doi.org/10.19088/k4d.2022.034.

Повний текст джерела
Анотація:
Malaria, human immune deficiency virus (HIV) and tuberculosis (TB) are leading causes of death and public health threat to millions in Democratic Republic of Congo (DRC). The DRC is the second most malaria affected sub-Saharan African country after Nigeria, with malaria being the leading cause of death in children under 5 years (Lechthaler et al., 2019). The HIV prevalence in the country in the adult population stands at 1%, with extensive variations by region (UNAIDS, 2021c). The DRC is considered a high burden country for TB and HIV infection (Linguissi et al., 2017). This rapid review empha
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Ndwiga, Charity, Harriet Birungi, Chi-Chi Undie, Shiphrah Kuria, Joseph Sitienei, and Sam Ochola. Integrating tuberculosis case finding and treatment into postnatal care. Population Council, 2011. http://dx.doi.org/10.31899/rh3.1033.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Mohammed, Shama, Rachel Glennerster, and Aamir Khan. Impact of mobile message reminders on tuberculosis treatment outcomes in Pakistan. International Initiative for Impact Evaluation, 2016. http://dx.doi.org/10.23846/ow1048.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Lewin, Simon, and Peter Steinmann. Do material incentives improve patient adherence in tuberculosis? SUPPORT, 2017. http://dx.doi.org/10.30846/1704152.

Повний текст джерела
Анотація:
Adherence to treatment for tuberculosis (TB) is frequently sub-optimal. However, good adherence is important for successful treatment and to minimize the risk of drug resistance. Adherence is also essential for different components of TB prophylaxis. Material incentives for patients to encourage them to take their treatment as prescribed, or to assist them in overcoming financial barriers to treatment, have been suggested as interventions to improve TB treatment adherence.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Davis, Alan R., Elizabeth A. Olmsted-Davis, Michael Heggeness, et al. Prevention and Treatment of Heterotopic Ossification. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada575292.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Treatment and prevention of tuberculosis" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії